#generic drugs
Related Stories (7)
Merck licenses experimental HIV pill to generic makers in 129 countries - Reuters
Merck licenses experimental HIV pill to generic makers in 129 countries Reuters
July 24, 2026Trump says generic drugs to face no US tariffs for 2 years, then 100% and 200% tariffs later - Reuters
Trump says generic drugs to face no US tariffs for 2 years, then 100% and 200% tariffs later Reuters
July 21, 2026FDA set to review Sandoz's generic GLP-1s - Reuters
FDA set to review Sandoz's generic GLP-1s Reuters
June 29, 2026Why Canada has generic Ozempic, and the US doesn't
Canada is the first G7 country to approve the lower cost weight-loss drugs, which are rolling out in pharmacies this month.
June 3, 2026Japan's Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds - Reuters
Japan's Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds Reuters
May 18, 2026Novartis misses quarterly sales, profit estimates as Entresto generics hit growth - Reuters
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth Reuters
April 28, 2026Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say - Reuters
Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say Reuters
February 25, 2026Related Pages (10)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda
BOSTON – A class-action lawsuit against Takeda Pharmaceuticals USA Inc. on behalf of direct purchasers of Amitiza and its generic equivalents ended today when a jury returned a verdict finding the pha
Law360
@media (max-width: 767px) { nav.navbar.visible-xs .mobile-navigation { display: flex !important; align-items: center !important; justify-content: space-betw
Takeda Pharmaceutical Faces $885 Million Verdict in Antitrust Case
A Boston jury has delivered a major blow to Takeda Pharmaceutical, holding the company accountable for $885 million in damages for its role in delaying a generic version of the constipation drug Amiti
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Novartis misses Q1 profit estimates on steep generic erosion
Group operating income is down by 12% at US$4.9 billion, below analyst expectations of US$5.1 billion Share [BASEL] Swiss drugmaker Novartis reported first-quarter core operating profit below market
Dr Reddy's files 'Obeda' trademark ahead of generic ozempic launch
Hyderabad-based Dr Reddy’s Laboratories has applied to trademark the brand name and logo “Obeda”, according to sources. The proposed brand is expected to be the company’s version of semaglutide, the
Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say
Listen to this article in summarized format Unlock AI Briefing and Premium Content (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Econo
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa